Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis
- 18 May 2020
- journal article
- editorial
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (10), 2096-2098
- https://doi.org/10.1111/tbj.13870
Abstract
Click on the article title to read more.Keywords
Funding Information
- Oncotest (NA)
This publication has 7 references indexed in Scilit:
- Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapynpj Breast Cancer, 2019
- Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trialCancer Research, 2019
- Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor–Positive, Node-Negative Breast CancerJournal of Clinical Oncology, 2018
- The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast CancerThe Breast Journal, 2017
- Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancerInternational Journal of Cancer, 2017
- Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutationsBreast Cancer Research and Treatment, 2016
- Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern IsraelInternational Journal of Cancer, 2011